Related Experiment Video
Updated: Aug 11, 2026

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
Published on: April 26, 2018
Polychlorinated biphenyls, dibenzo-p-dioxins, and dibenzofurans and birth weight and immune and thyroid function in
Insights
Polychlorinated biphenyls (PCBs) and related chemicals show no consistent adverse effects on infant weight, immune, or thyroid function. Studies found normal ranges and inconsistent correlations with birth weight, indicating limited clinical evidence of harm.
Area of Science:
- Environmental Health
- Pediatric Toxicology
- Public Health
Background:
- Polychlorinated biphenyls (PCBs) are persistent organic pollutants with potential health implications.
- Infant exposure to environmental toxins is a significant public health concern.
- Assessing the impact of PCBs on infant development is crucial for risk assessment.
Purpose of the Study:
- To review existing literature on the clinical evidence of PCB exposure effects on infant and child health.
- To evaluate the impact of PCBs on birth weight, immune function, and thyroid function in newborns and children.
- To determine the consistency and significance of reported correlations between PCB exposure and adverse health outcomes.
Main Methods:
- Systematic review of publications examining PCB exposure and infant/child health outcomes.
- Analysis of studies reporting on birth weight, thyroid function, and immune function in relation to PCB levels.
- Evaluation of reported statistical significance and variance explained by PCB exposure.
Main Results:
- No clinical evidence found that PCBs adversely affect infant weight, immune, or thyroid function in healthy mothers' offspring.
- Birth weights consistently fell within normal ranges across reviewed studies.
- Correlations between PCB exposure or contaminated fish intake and birth weight were inconsistent; thyroid and immune function remained within normal ranges.
Conclusions:
- Current literature lacks robust clinical evidence linking PCB exposure to adverse effects on infant weight, immune, or thyroid function.
- Observed statistical differences in some studies were minor and accounted for little variance.
- Further research with standardized laboratory reference values may be needed to clarify potential subtle effects.
Abstract:
None of the publications reviewed provide clinical evidence that PCBs (polychlorinated biphenyls) and related chemicals adversely affect weight, immune, or thyroid function in infants or children born to healthy mothers. Birth weights of term infants fell within the normal range in all studies. The greatest difference between comparison groups was reported by G. G. Fein et al. (1984a, Intrauterine Exposure of Humans to PCBs: Newborn Effects, EPA-600/3-84-060, Environmental Protection Agency; 1984b, J. Pediatr. 105, 315-320). P. R. Taylor et al. (1989, Am. J. Epidemiol. 129, 395-406) reported smaller differences in occupationally exposed women and E. Dar et al. (1992, Environ. Res. 59, 189-201) found that women with higher PCB serum levels had larger babies. S. Patandin et al. (1998, Pediatr Res. 44, 538-545) found a negative association of PCB concentrations in maternal or cord plasma and birth weight of breast and formula-fed infants combined but not when breast-fed infants were analyzed separately. L. Rylander et al. (1995, Scand. J. Work Environ. Health 21, 368-375) reported decreased birth weights with higher dietary intake of contaminated fish. Thus, correlations between PCB exposure or polluted fish ingestion and birth weight were inconsistent. Thyroid and immune function were also within the normal range. In none of the papers were normal laboratory reference values provided and overall the statistically significant differences accounted for little of the variance.
Related Concept Videos
Teratogenicity
Pharmacokinetics in Pediatric Patients: Drug Distribution
Environmental Influences on Intelligence
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

